Neurodegenerative Diseases: current treatment algorithm and potential investment opportunities covered in a lates research report

This report examines the entire neurodegenerative disease therapy area, with a particular focus on the three most prevalent neurodegenerative disorders: Alzheimer’s disease (AD), Parkinson’s disease (PD) and multiple sclerosis (MS).

Pune, India - March 14, 2018 /MarketersMedia/ —

AD and PD represent the most pressing challenges within the disease cluster, due to rapidly increasing prevalence driven by aging populations. Both AD and PD remain ineffectively treated despite substantial investment into R&D by pharmaceutical companies, due to high clinical trial failure rates. As a result there are no disease-modifying therapies for these two indications, with available treatments able to provide only marginal symptomatic relief. MS, the autoimmune disease of the CNS, contrasts with the rest of this cluster, as it affects a different population demographic, and has a lucrative pharmacological market following breakthrough success in the past decade.
Access Report Details at:
Reasons To Buy
• Appreciate the current clinical and commercial landscapes by considering disease symptoms, pathogenesis, etiology, co-morbidities and complications, epidemiology, diagnosis, prognosis and treatment options.
• Identify leading products and key unmet needs within the market.
• Recognize innovative pipeline trends by analyzing therapies by stage of development, molecule type and molecular target.
• Assess the therapeutic potential of first-in-class targets. Using proprietary matrix assessments, first-in-class targets in the pipeline have been assessed and ranked according to clinical potential. Individual matrix assessments are provided for targets categorized into four major classes: protein misfolding, neuromodulators, immunomodulators and neuroprotectants. The most promising first-in-class targets are reviewed in greater detail.
• Consider first-in-class pipeline products with no prior involvement in licensing and co-development deals, which may represent potential investment opportunities.
Get this report at:
• Unmet need is extremely high in AD and PD, with MS showing continued promise in the development of effective therapies
• What are the most important etiological risk factors and pathophysiological processes implicated in AD, PD and MS?
• What is the current treatment algorithm?
• How effective are current therapies for these indications, and how does this impact prognosis?
• The AD pipeline is large and contains a very high proportion of first-in-class product innovation.
• Which molecule types and molecular targets are most prominent across AD, PD and MS?
• What are the connections, in terms of first-in-class innovation, between AD, PD and MS?
• Which first-in-class targets are most promising?
Inquire for more details at:

Contact Info:
Name: Shirish Gupta
Organization: The Market Reports
Address: SF-29, Sacred World, Wanawadi
Phone: 16314071315

Source URL:

For more information, please visit

Source: MarketersMedia

Release ID: 314330

Latest News

Asian shares slump on fears of trade war between US, China

Mar 23, 2018

HONG KONG — Asian stock markets slumped Friday after Beijing responded to the Trump administration's tariff hikes by saying it may slap higher import duties on a range of U.S. goods, ratcheting up fears of a trade war. KEEPING SCORE: Japan's benchmark Nikkei 225 index plunged 3.8 percent to 20,765.74 and South Korea's Kospi tumbled 2.3 percent to 2,439.53. Hong Kong's Hang Seng lost 3.4 percent to 30,001.57 and the Shanghai Composite in mainland China sank 2.9 percent to 3,169.19. Australia's S&P/ASX 200 skidded 1.9 percent to 5,824.50. TRADE WAR: China unveiled a list of U.S. goods including pork, apples...

China may hike tariffs on US pork, aluminum, other goods

Mar 23, 2018

BEIJING — China announced a list of U.S. goods including pork, apples and steel pipe on Friday on which it might raise tariffs in an escalating trade dispute with President Donald Trump. The Commerce Ministry called on Washington to negotiate a settlement to the conflict over higher U.S. import duties on steel and aluminum but set no deadline. Beijing's move appeared to be a calculated step aimed at increasing domestic American pressure on Trump by making clear which exporters, especially farming areas that supported the president in the 2016 election, might be hurt. The dispute has weighed on global financial...

Communist Party will regulate China's media, film industry

Mar 23, 2018

BEIJING — Chinese state media will be getting more propaganda now that the Communist Party has announced it will be in direct control of broadcasters and the regulators of everything from movies and TV to books and radio programs. The move is part of a push by President Xi Jinping — emboldened by the removal of term limits on his time in office — to tighten party supervision over broad swaths of Chinese public life as he pushes for what he calls "unity in thought" among officials and citizens. Analysts say having direct oversight of the media will help the...

Trump orders huge tariffs on China, raises trade war worries

Mar 23, 2018

WASHINGTON — Primed for economic combat, President Donald Trump set in motion tariffs on as much as $60 billion in Chinese imports to the U.S. on Thursday and accused the Chinese of high-tech thievery, picking a fight that could push the global heavyweights into a trade war. China threatened retaliation, and Wall Street cringed, recording one of the biggest drops of Trump's presidency. But he declared the U.S. would emerge "much stronger, much richer." It was the boldest example to date of Trump's "America first" agenda, the culmination of his longstanding view that weak U.S. trade policies and enforcement have...

As US gets tough with China, Wall Street gets weak-kneed

Mar 23, 2018

NEW YORK — The prospect of a full-blown trade war between the world's two biggest economies rattled investors Thursday, sending stocks to their biggest loss in six weeks. The Dow Jones industrial average plunged more than 700 points, as President Donald Trump announced plans to slap tariffs on Chinese imports. The Chinese government vowed to defend itself. Investors worried that if the dispute escalated, China will counterpunch with restrictions of its own, hurting American exports of airplanes, construction equipment and other goods. It didn't take long for China to threaten to hit back. The Commerce Ministry announced a list of...

Financial Markets

About Us

Established in 2015, The Upstocker provides insights on financial reports, commentary, and investment data to traders so that you can make better investment decisions.

Contact us: sales[at]

Subscribe Now!